1.Ibeanu, G C GC and 9 more authors. 1998-04 An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in Caucasians. [PMID:10022751]
2.Foster, D J DJ, Somogyi, A A AA and Bochner, F F. 1999-04 Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4. [PMID:10233205]
3.Ibeanu, G C GC and 9 more authors. 1999-08 A novel transversion in the intron 5 donor splice junction of CYP2C19 and a sequence polymorphism in exon 3 contribute to the poor metabolizer phenotype for the anticonvulsant drug S-mephenytoin. [PMID:10411572]
4.Roddam, P L PL and 6 more authors. 2000-10 Poor metabolizers at the cytochrome P450 2D6 and 2C19 loci are at increased risk of developing adult acute leukaemia. [PMID:11037802]
5.Hartley, J L JL, Temple, G F GF and Brasch, M A MA. 2000-11 DNA cloning using in vitro site-specific recombination. [PMID:11076863]
6.Griese, E U EU and 8 more authors. 2001-02 Allele and genotype frequencies of polymorphic cytochromes P4502D6, 2C19 and 2E1 in aborigines from western Australia. [PMID:11207032]
7.Furuta, T T and 8 more authors. 2001-03 Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin. [PMID:11240980]
8.Povey, A A and 5 more authors. 2001-03 Cytochrome P2 polymorphisms and susceptibility to scleroderma following exposure to organic solvents. [PMID:11263781]
9.Dandara, C C and 7 more authors. 2001-04 Genetic polymorphism of CYP2D6 and CYP2C19 in east- and southern African populations including psychiatric patients. [PMID:11372584]
10.Sakai, T T and 11 more authors. 2001-06 CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects. [PMID:11474773]